Skip to main content

Table 4 Hospital course of the studied VA-ECMO-treated patients

From: Acute vascular complications of femoral veno-arterial ECMO: a single-centre retrospective study

Studied criteria All patients Limb ischemia group No limb ischemia group P value
Acute Kidney injury 39 (60) 21 (100) 18 (40.9) < 0.001
Renal replacement therapy 27 (41.5) 12 (57.1) 15 (34.1) 0.07
Cerebrovascular stroke 13 (20) 5 (23.8) 8 (18.2) 0.74
Cerebral ischemic stroke 7 (11.9) 3 (17.6) 4 (9.5) 0.39
Intracerebral haemorrhage 6 (10.2) 2 (11.8) 4 (9.5) 0.9
ICU days 19 (3–191) 19 (10–93) 17 (3–191) 0.028
Ventilator days 10 (2–191) 14 (5–81) 9 (2–191) 0.053
Gastrointestinal bleeding 14 (21.5) 4 (19) 10 (22.7) 0.92
Atrial fibrillation 25 (38.5) 9 (42.9) 16 (36.4) 0.61
Intracardiac thrombi 4 (6.2) 1 (4.8) 3 (6.8) 0.9
ECMO circuits thrombi 4 (6.2) 1 (4.8) 3 (6.8) 0.9
ECMO days before ischemia 6 (1–21) 6 (1–21) ------- ----
ECMO days 8 (3–40) 7 (4–40) 8 (3–32) 0.27
Changing to central VA-ECMO 3 (4.6) 2 (9.5) 1 (2.3) 0.29
Changing to LVAD 11 (16.9) 4 (19) 7 (15.9) 0.34
Decannulation and no MCS 51 (78.5) 15 (71.4) 36 (81.8) 0.41
Hospital mortality 29 (44.6) 9 (42.9) 20 (45.5) 0.84
SOFA score day 1 12 (8–21) 10 (8–21) 14 (8–21) 0.008
SOFA score day 3 13 (6–24) 10 (7–22) 14 (6–24) 0.034
∆ 1 SOFA − 1 (− 5 to 6) 1 (− 4 to 6) − 2 (− 5 to 6) 0.12
SOFA score day 5 10 (5–24) 9 (6–21) 10 (5–24) 0.45
∆ 2 SOFA − 2 (− 7 to 9) 0 (− 5 to 8) − 3 (− 7 to 9) 0.14
  1. Data are presented as number (%) or median (IQR)